The technique was successful in a proof-of-concept animal study, but human trials are a long way off. 

Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.

Michael Garshick, MD, examines the role of inflammation in coronary disease development, detailing how this risk factor can be detected and treated.

Researchers explored data from nearly 17,000 U.S. heart transplant candidates, developing an updated model that ranks patients based on their mortality risk. 

“CT scan” was the third most-searched term among healthcare consumers, and “ultrasound” was No. 4, according to Fair Health. 

“People say safety regulations are written in blood. I don’t want to bleed.”  

Patients with such impediments also are more likely to present to practices with late-stage disease, experts detailed in JAMA Network Open.  

New Jersey-based Impulse Dynamics says it will use the new financing to fund clinical research and continue developing advanced heart failure devices.